C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/24 (2006.01) A61K 31/472 (2006.01) A61K 31/517 (2006.01) A61P 9/00 (2006.01) C07D 239/88 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2664335
Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds.
L'invention concerne de nouveaux dérivés de 2H-isoquinolin-1-one et 3H-quinazolin-4-one substitués, utiles en tant qu'inhibiteurs de la rho-kinase ainsi que pour traiter divers troubles et maladies dont la médiation ou le prolongement est assuré par l'activité de la rho-kinase, y compris des maladies cardiovasculaires. L'invention concerne également des compositions pharmaceutiques comprenant de tels composés, des procédés pour utiliser de tels composés et des processus pour fabriquer de tels composés.
Bosanac Todd
Ginn John David
Hickey Eugene Richard
Kirrane Thomas Martin
Liu Weimin
Aerie Pharmaceuticals Inc.
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Rho kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rho kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rho kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1520454